Please ensure Javascript is enabled for purposes of website accessibility

Why ShockWave Medical Stock Is Soaring Today

By Prosper Junior Bakiny - Mar 30, 2021 at 1:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company announced preliminary first-quarter results.

What happened

Shares of ShockWave Medical (SWAV 0.76%) are trading higher on Tuesday after the company released preliminary revenue results for the first quarter. ShockWave Medical also gave an update on the rollout of its C2 System, which was approved by the U.S. Food and Drug Administration (FDA) in February. ShockWave Medical's stock was up by 15.5% as of 12:50 p.m. EDT, after rising by as much as 18.7% earlier today.

So what

ShockWave Medical is best known for its intravascular lithotripsy (IVL) technology to treat atherosclerotic cardiovascular disease (the buildup of plaque in the arteries). Lithotripsy is a medical procedure that uses shockwaves to break up stones in the kidney. Last month, the company's C2 Coronary Intravascular Lithotripsy Catheter earned approval from health industry regulators in the U.S. This device helps open up calcified arteries to allow for stent implantation.

Hand drawing upward-bound graph

Image source: Getty Images.

Today, ShockWave Medical announced that the launch of this device in the U.S. market is going as planned. For instance, the company said that more than 120 customers in the U.S. have purchased an average of six units of the C2 System launch kit, among other milestones. ShockWave Medical also provided top-line estimates for the first quarter. The company expects revenue between $31 million and $32 million, which would represent an increase between 104% to 111% compared to the prior-year quarter. Meanwhile, analysts expect the company's revenue to come in at $24.9 million for the quarter.

Now what

ShockWave Medical could see even brighter days ahead. The company is barely scratching the surface of its addressable market, which it estimates to be worth more than $6 billion. With solid opportunities ahead, ShockWave Medical is a healthcare stock worth serious consideration. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ShockWave Medical Stock Quote
ShockWave Medical
SWAV
$163.56 (0.76%) $1.24

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.